NVO

Novo Nordisk
NVO

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$316.64B
EV
$328.73B
Shares Outstanding
-
Beta
-

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$86.71
P/E 2025E
17.38x
P/Revenue 2025E
6.11x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Novo Nordisk A/S

gainify
NVO

Novo Nordisk A/S

NVO

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates i...

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Jorgensen, Lars

Employees

77,406

IPO Date

1981-04-30

Headquarters

Novo Alle 1, Bagsvaerd, Capital Region of Denmark, 2880, Denmark

gainifypowered-by-sp
navigation.socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.